NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing - Thailand PR News

 - [Banking](https://thailandbusinessnews.net/category/banking/)
- [Companies](https://thailandbusinessnews.net/category/companies/)
- [Economy](https://thailandbusinessnews.net/category/economy/)
- [Press Releases](https://thailandbusinessnews.net/category/press-release/)
    - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/)
- [Tech](https://thailandbusinessnews.net/category/tech/)
- [Tourism](https://thailandbusinessnews.net/category/tourism/)

    - [Press Release](https://thailandbusinessnews.net/category/press-release/)

# NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing

   #####  Up next

  ![UOB advances wealth ambitions with strategic distribution partnership with Allianz Global Investors](https://i0.wp.com/mmx.prnasia.com/media/MS1964300/20260805014641EDT_image_1.jpg?resize=200%2C110&ssl=1 "UOB advances wealth ambitions with strategic distribution partnership with Allianz Global Investors")

 [](https://thailandbusinessnews.net/press-release/uob-advances-wealth-ambitions-with-strategic-distribution-partnership-with-allianz-global-investors/)

 ###### [UOB advances wealth ambitions with strategic distribution partnership with Allianz Global Investors](https://thailandbusinessnews.net/press-release/uob-advances-wealth-ambitions-with-strategic-distribution-partnership-with-allianz-global-investors/)

  Published on 05 August 2026 #####  Author

#####   [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/)

  ##### Tags

- [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/)

![](https://mmx.prnasia.com/media/MS1962209/nuecellbio_Logo_primary_RGB.jpg?id=OA2820586&p=medium600 "logo")SAN DIEGO, Aug. 5, 2026 /PRNewswire/ — NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused on advancing modern cell therapies from scientific discovery through clinical readiness, today announced its launch as a specialist partner uniquely positioned to advance and accelerate cell-based treatments to patients.

 [![NueCell Bio Primary Logo](https://mmx.prnasia.com/media/MS1962209/nuecellbio_Logo_primary_RGB.jpg?id=OA2820586&p=medium600 "NueCell Bio Primary Logo")](https://mmx.prnasia.com/media/MS1962209/nuecellbio_Logo_primary_RGB.jpg?id=OA2820586&p=medium600)

NueCell Bio is led by a team possessing unprecedented experience in the advanced therapies market. The team’s industry-leading expertise in supporting customers developing novel cell therapies positions NueCell Bio to offer customizable modular technologies to engineer cells and develop scalable, GMP-ready manufacturing processes and analytics for a wide range of cell therapies. NueCell Bio works across a broad spectrum of groundbreaking science in this field, including CAR-T, stem cells, iPSC-derived therapies, gene-edited cells, and tissue repair platforms – supporting both autologous and allogeneic products.

NueCell Bio is headquartered in the Sorrento Valley area of San Diego – a leading hub for biotechnology and advanced therapy development – in a 26,300 square-foot, state-of-the-art facility that specializes in translational services for cell therapy.

"Advanced therapies, including cell therapies, are expanding rapidly across the United States, Europe, Japan, South Korea, and emerging biotechnology markets," said Michael Wourms, Chief Executive Officer of NueCell Bio. "The industry does not suffer from a shortage of scientific breakthroughs, it suffers from a difficulty in efficiently converting these breakthroughs into therapies that can be evaluated, manufactured, and ultimately delivered to patients. That translational phase is where NueCell Bio is focused. By combining NueCell’s flexible and modular translational development solutions with scientific expertise, analytical capabilities, and a proven track record, we believe we are uniquely positioned to help innovators advance the next generation of cellular therapies for cancer, immune-mediated diseases, tissue repair and regeneration, and other areas of significant unmet medical need."

"NueCell Bio is distinctively positioned to advance cell therapies from early discovery through clinical development," said Dr. Uma Lakshmipathy, Co-founder and Chief Science Officer. "Cell therapies have been proven to work and are commercially available, but manufacturing them at scale is still slow and expensive, largely because each therapy is biologically unique. The most promising therapies often face the greatest development complexity. Every program follows a different path, and the scientific, analytical, and development challenges that create risk for one company may be very different for another. Our role is to understand where each program is today, identify what is needed to move it forward, and apply the right expertise and resources at the appropriate time to help accelerate its path towards clinical readiness. By combining modular technology stacks of scientific, analytical, process development, and manufacturing-enabling capabilities, NueCell Bio is uniquely positioned to help innovators navigate critical development challenges and advance promising therapies more efficiently to reach patients faster."

Renowned University of Pennsylvania Professor, Dr. Bruce Levine, a member of NueCell Bio’s Scientific Advisory Board, said, "The ecosystem of advanced therapies I have been part of for many years is moving rapidly and NueCell Bio helps meet the demand by supporting the development of life-altering and life-saving treatments that were previously only a distant hope in many challenging areas of medicine. To reach more patients, the future of cell therapy lies in expanding beyond oncology towards additional broad indications, while still addressing low-incidence diseases. To support this goal, the incorporation of precision engineering, efficient manufacturing processes and advanced analytics is essential."

"The ability to genetically engineer cells to have the characteristics to treat specific diseases is key, but another very important aspect is successfully advancing these programs from lab research into a GMP manufacturing process that is capable of consistently delivering cells in sufficient quantities and with required characteristics and viability," said Dr. Gabor Veres, a member of NueCell Bio’s Scientific Advisory Board. "With the expertise of our team and state-of-the-art capabilities, NueCell Bio is well positioned to support customers by developing reliable, consistent and scalable processes suited to clinical manufacturing and future commercialization."

Addressing the acquisition and the future, Dr. Richard Snyder, Chair of the Board and Co-founder of NueCell Bio, said, "I am incredibly excited by how this business brings together such an extraordinary caliber of leaders in the field, along with the team and assets transitioning to NueCell Bio. Beyond this, our team’s significant industry networks are an equally strong factor in establishing NueCell as a highly differentiated cell therapy services business positioned to address the needs of current and future customers."

In connection with the transaction, Kineticos Life Sciences served as exclusive advisor to NueCell Bio, with Goodwin Procter LLP serving as legal counsel.

**About NueCell Bio**

NueCell Bio is a San Diego-based company that works with academic institutions, biotechnology companies and pharmaceutical companies to advance cell therapies from concept and early research into clinical development. Our team brings deep expertise in biology, cell engineering, bioprocessing, and advanced technology integration, supported by modular technology stacks that can be tailored to each program.

NueCell Bio gives clients access to experienced design, development and CMC expertise. By combining scientific excellence, strong quality systems, scalable operations, and ‘customer-first’ engagement, NueCell Bio helps accelerate the journey from scientific discovery to clinical delivery. For more information, visit [www.NueCellBio.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4743591-1&h=1330011729&u=http%3A%2F%2Fwww.nuecellbio.com%2F&a=www.NueCellBio.com)

**Media contact:**

Connor Halverson
Tel: +1 212 366 4455
Email: <connor@thatsnice.com>

[Source link ](http://www.prnasia.com/story/archive/5016999_AE16999_0?rand=89749)

```
This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
```

  #####  You May Also Like

  [](https://thailandbusinessnews.net/press-release/firmable-raises-14m-series-a-to-take-ai-native-sales-platform-global/) ## Firmable Raises $14m Series A to Take AI-Native Sales Platform Global

  MELBOURNE, Australia, March 2, 2026 /PRNewswire/ — Firmable, Asia-Pacific’s leading AI (artificial…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- March 2, 2026

   [](https://thailandbusinessnews.net/press-release/eoptolink-launches-1-6t-osfp-2vr4-transceivers-using-200g-vcsels/) ## Eoptolink Launches 1.6T OSFP 2VR4 Transceivers Using 200G VCSELs

  SAN FRANCISCO, March 29, 2025 /PRNewswire/ — Eoptolink Technology Inc., Ltd. (SZSE:…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- March 29, 2025

   [](https://thailandbusinessnews.net/press-release/lg-energy-solution-and-toyota-tsusho-establish-a-battery-recycling-joint-venture-in-the-u-s/) ## LG Energy Solution and Toyota Tsusho Establish a Battery Recycling Joint Venture in the U.S.

  The joint venture company Green Metals Battery Innovations will construct a pre-processing…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- June 19, 2025

 ##### Most Read

- [![BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/bitraser-receives-frost-sullivans-2026-global-customer-value-leadership-recognition-for-data-erasure-for-used-electronics/ "BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics") [BitRaser Receives Frost &amp; Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics](https://thailandbusinessnews.net/press-release/bitraser-receives-frost-sullivans-2026-global-customer-value-leadership-recognition-for-data-erasure-for-used-electronics/ "BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics")
- [![Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/celltrion-to-present-six-abstracts-in-inflammatory-bowel-disease-ibd-at-2025-digestive-disease-week-ddw/ "Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)") [Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)](https://thailandbusinessnews.net/press-release/celltrion-to-present-six-abstracts-in-inflammatory-bowel-disease-ibd-at-2025-digestive-disease-week-ddw/ "Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)")
- [![Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection](https://i0.wp.com/r2.thailandbusinessnews.net/2025/03/1742866040_Power_Up_Teyvat_Journey_UGREEN_Launches_Genshin_Impact_Co_Branded_Charging.jpg?fit=600%2C324&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/power-up-the-teyvat-journey-ugreen-launches-genshin-impact-co-branded-charging-collection-4/ "Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection") [Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection](https://thailandbusinessnews.net/press-release/power-up-the-teyvat-journey-ugreen-launches-genshin-impact-co-branded-charging-collection-4/ "Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection")
- [![Gemtek Technology to Showcase 800G Optical Module, Software Cloud, and AI Router at COMPUTEX TAIPEI 2025](https://i0.wp.com/r2.thailandbusinessnews.net/2025/05/image_5030926_26813148.jpg?fit=599%2C450&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/gemtek-technology-to-showcase-800g-optical-module-software-cloud-and-ai-router-at-computex-taipei-2025/ "Gemtek Technology to Showcase 800G Optical Module, Software Cloud, and AI Router at COMPUTEX TAIPEI 2025") [Gemtek Technology to Showcase 800G Optical Module, Software Cloud, and AI Router at COMPUTEX TAIPEI 2025](https://thailandbusinessnews.net/press-release/gemtek-technology-to-showcase-800g-optical-module-software-cloud-and-ai-router-at-computex-taipei-2025/ "Gemtek Technology to Showcase 800G Optical Module, Software Cloud, and AI Router at COMPUTEX TAIPEI 2025")
- [![FlexiAchiever Savings Plan Flexible financial solution integrating wealth accumulation, liquidity and legacy planning to save up for a world of possibilities](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/flexiachiever-savings-plan-flexible-financial-solution-integrating-wealth-accumulation-liquidity-and-legacy-planning-to-save-up-for-a-world-of-possibilities/ "FlexiAchiever Savings Plan Flexible financial solution integrating wealth accumulation, liquidity and legacy planning to save up for a world of possibilities") [FlexiAchiever Savings Plan Flexible financial solution integrating wealth accumulation, liquidity and legacy planning to save up for a world of possibilities](https://thailandbusinessnews.net/press-release/flexiachiever-savings-plan-flexible-financial-solution-integrating-wealth-accumulation-liquidity-and-legacy-planning-to-save-up-for-a-world-of-possibilities/ "FlexiAchiever Savings Plan Flexible financial solution integrating wealth accumulation, liquidity and legacy planning to save up for a world of possibilities")
- [![GIGABYTE Announces World's First DDR5-7200 at Full 256GB with CQDIMM at CES 2026](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/gigabyte-announces-worlds-first-ddr5-7200-at-full-256gb-with-cqdimm-at-ces-2026/ "GIGABYTE Announces World's First DDR5-7200 at Full 256GB with CQDIMM at CES 2026") [GIGABYTE Announces World's First DDR5-7200 at Full 256GB with CQDIMM at CES 2026](https://thailandbusinessnews.net/press-release/gigabyte-announces-worlds-first-ddr5-7200-at-full-256gb-with-cqdimm-at-ces-2026/ "GIGABYTE Announces World's First DDR5-7200 at Full 256GB with CQDIMM at CES 2026")

##### Subscribe via Email

 Enter your email address to subscribe and receive notifications of new posts by email.

  Email Address

       Subscribe

  [](https://thailandbusinessnews.net/press-release/fgr-advances-carbon-fibre-commercialisation-with-aeropreg-agreement/) ![FGR advances carbon fibre commercialisation with Aeropreg agreement](https://i0.wp.com/mmx.prnasia.com/media/MS1709139/FGR-Logo-Main-Tag-Logo.jpg?resize=260%2C140&ssl=1 "FGR advances carbon fibre commercialisation with Aeropreg agreement")

 ## FGR advances carbon fibre commercialisation with Aeropreg agreement

  Highlights First Graphene enters Development and Commercialisation Agreement with…

   [](https://thailandbusinessnews.net/press-release/tigerair-taiwan-expands-its-network-with-new-connected-travel-platform-powered-by-dohop/) ![Tigerair Taiwan Expands Its Network With New Connected Travel Platform, Powered by Dohop](https://i0.wp.com/mmx.prnasia.com/media/MS1882701/Dohop-Tigerair-Taiwan-tigerhop.jpg?resize=260%2C140&ssl=1 "Tigerair Taiwan Expands Its Network With New Connected Travel Platform, Powered by Dohop")

 ## Tigerair Taiwan Expands Its Network With New Connected Travel Platform, Powered by Dohop

  With Scoot as its first airline partner, tigerhop expands Dohop’s footprint in…

   [](https://thailandbusinessnews.net/press-release/csl-and-alentis-announce-global-partnership-to-develop-and-commercialise-lixudebart-for-rare-kidney-and-liver-diseases/) ## CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases

  Alentis to receive US$355 million initial payment and up to US$1.2 billion…

   [](https://thailandbusinessnews.net/press-release/pmet-signs-letter-of-intent-with-matagami-for-spodumene-concentrate-transshipment-to-the-rail-network/) ## PMET Signs Letter of Intent with Matagami for Spodumene Concentrate Transshipment to the Rail Network

  Letter of Intent ("LOI") advances a key component of the planned concentrate…
<!-- Performance optimized by Docket Cache: https://wordpress.org/plugins/docket-cache -->
